A global pharma player producing active pharmaceutical ingredients (APIs) and finished dose forms (FDFs), wanted to design an EU CSRD compliant future for their business. The client’s ambition was to develop a Sustainability Roadmap to 2027, that by focussing on highest impact topics they would be able to accelerate their efforts – and allow them to seek a higher valuation …
Setting a global pharma business on the pathway to sustainability excellence
